Recent Stories
American Biotech — The Future Can’t Be Won Without It.RSI is AI Building AI. What DC needs to know about it. Keeping the Human in Medicine: Two AI CoLab Researchers on What Machines Can’t ReplaceSomeone Is Hacking the Freezers. Pay Attention.Thinking of Running in 2028? Start HereWhat the Lame Duck Session Has to Do With the Ultimate 21st-Century Power Tool: Robots

The Wave

Senatein sessionHousein session
Refreshed just now
News

Cancer Vaccines Are Advancing. Can Regulators Keep Up?

Why it’s here: Covers cancer vaccine advances and the FDA's regulatory challenges for personalized biotech therapies, plus HHS cuts to mRNA investments, which fall squarely in biotechnology federal policy, though the piece argues for ending FDA's drug-approval monopoly from a libertarian perspective.

Trace across the board

Item

Coverage

2 outlets · first seen 2d ago

Connected

22 links

About

  • Congress
  • Robert F. Kennedy Jr.
  • Food and Drug Administration
  • Moderna
  • HHS
  • Merck

Analytics cookies help us see how the site is used. They only run if you accept. Privacy Policy